Kochański & Partners has advised VC fund Inovo Venture Partners on its investment in Jutro Medical
Kochański & Partners has advised Inovo Venture Partners VC fund on its latest investment in the Jutro Medical startup, consisting of a modern healthcare centre with telemedicine services. The transaction was made in a seed round, with Inovo as the lead investor. Other investors participating in the round included other VC funds: Rheingau Founders, Market One Capital, and business angels.
Work on the transaction involved performing a due diligence investigation of the company and negotiating transaction documentation, including the investment agreement. The team led by Paweł Mardas included: Szymon Balcerzak, Piotr Gałka, Tomasz Szambelan, and Anna Golenia.
“The Covid-19 pandemic has accelerated the development of advanced medical services, fusing high quality with convenience and ease of contact. Jutro Medical provides rapid access to quality healthcare, from the comfort of your own home. This is yet another transaction by the Inovo fund in the medtech sector, demonstrating the growing interest in investing in this market segment.” – commented Paweł Mardas, Head of M&A at Kochański & Partners.
Inovo Venture Partners is a venture capital fund supporting technology companies in Poland and Central and Eastern Europe. Through its two funds, Inovo manages assets with a total value of PLN 275 million. Inovo’s portfolio currently boasts 16 companies, including among others Booksy, Spacelift, Infermedica and SunRoof. Jutro Medical has been in the fund’s portfolio since late 2020. Now, as a result of the recently completed seed round, Inovo has significantly increased its stake in the company, with Jutro Medical becoming its largest investment to date.